Evidence map›Paper›PMID 41815184›Full record

ArticleBlood cell therapy2026

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers.

Kimikazu Yakushijin, Jacinta Perram, Aloysius Ho, Tasneem Farzana, Hiroatsu Iida, Jong Wook Lee, Yoshihiro Inamoto, Biju George, Depei Wu, Ritsuro Suzuki and 22 more

Abstract read
In one paragraph

Article in Blood cell therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Kimikazu YakushijinMedical Oncology and Hematology, Kobe University Hospital, Kobe, Japan.
Jacinta PerramHaematology and Bone Marrow Transplant, St Vincent's Hospital Sydney, Sydney, NSW, Australia.
Aloysius HoHaematology, Singapore General Hospital, Singapore, Singapore.
Tasneem FarzanaBMT, National Institute of blood diseases and bone marrow transplantation (Lahore campus), Karachi, Pakistan.
Hiroatsu IidaHematology/Cell Therapy, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Jong Wook LeeHematology-Oncology, Hanyang University Seoul Hospital, Seoul, Republic of Korea.
Yoshihiro InamotoHematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Biju GeorgeDepartment of Haematology, Christian Medical College Vellore, Vellore, India.
Depei WuDepartment of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China.
Ritsuro SuzukiHematology and Oncology, Shimane University, Izumo, Japan.
Maryam BehfarPediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran, Iran.
He HuangBone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Thiti AsawapanumasDivision of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Philip RowlingsHaematology, Calvary Mater Newcastle, Waratah, Australia.
Bishesh S PoudyalClinical hematology and bone marrow transplant, Civil Service Hospital, Kathmandu, Nepal.
Damai SantosaDivision of Hematology Medical Oncology, Department of Internal Medicine, Diponegoro University/Dr. Kariadi Hospital, Semarang, Indonesia.
Aye Aye GyiDepartment of Clinical Haematology, North Okkalapa General Hospital, Yangon, Myanmar.
Otgonbat AltangerelDepartment of Hematology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Chinadol WanitpongpunInternal Medicine, Srinagarind, Khon Kaen University Hospital, Khon Kaen, Thailand.
Gin Gin GanDepartment of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Satoshi IyamaHematology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Shahid IqbalBone Marrow Transplant Data Management Section, Armed Forces Bone Marrow Transplant Centre (AFBMTC), Rawalpindi, Pakistan.
Mani RamziHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Alka KhadwalClinical Hematology & Medical Oncology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Jun KatoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Joycelyn SimDepartment of Medicine, Queen Mary Hospital, Hong Kong, China.
Jessica ChengHaematology and Bone Marrow Transplant, St Vincent's Hospital Sydney, Sydney, NSW, Australia.
David MaHaematology and Bone Marrow Transplant, St Vincent's Hospital Sydney, Sydney, NSW, Australia.
Yi Xuan ChuaDepartment of Pharmacy, KK Women's and Children's Hospital, Singapore, Singapore.
Shinichiro OkamotoDivision of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Minako IidaPromotion for Blood and Marrow Transplantation, Aichi Medical University, School of Medicine, Nagakute, Japan.
Shigeo FujiHematology, Osaka International Cancer Institute, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antiemetic therapy is an essential component of supportive care following hematopoietic stem cell transplantation (HSCT). Chemotherapy and irradiation used in conditioning regimens frequently induce severe nausea and vomiting, which can significantly impair patients' quality of life. Although recent guidelines recommend a triple combination of a 5-hydroxytryptamine-3 (5-HT

Indexed as

antiemeticschemotherapy-induced nausea and vomitinginternational survey

Identifiers

PMID41815184
PMCPMC12971318

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.